Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer’s disease that features clinical information for self-care and drug therapy options, as well as related cost information.
Shortages improve for Lilly’s GLP-1 weight loss drugs, bumping sales forecast by $3bn – Pharmaceutical Technology
Eli Lilly (Indianapolis, IN, US) and Novo Nordisk (Bagsvaerd, Denmark) have announced that the supply of their GLP-1 weight loss drugs has improved, with the